Ionis Pharmaceuticals Inc
NASDAQ:IONS
Ionis Pharmaceuticals Inc
Revenue
Ionis Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
Revenue
$787.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
18%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Ionis Pharmaceuticals Inc
Revenue Breakdown
Breakdown by Geography
Ionis Pharmaceuticals Inc
Breakdown by Segments
Ionis Pharmaceuticals Inc
Total Revenue:
787.6m
USD
|
Research And Development Revenue:
479.1m
USD
|
Collaborative Agreement Revenue:
352.7m
USD
|
Commercial:
308.6m
USD
|
Spinraza Royalties:
240.4m
USD
|
Other Commercial:
68.2m
USD
|
Product:
34.9m
USD
|
Licensing And Other Royalties:
33.3m
USD
|
See Also
What is Ionis Pharmaceuticals Inc's Revenue?
Revenue
787.6m
USD
Based on the financial report for Dec 31, 2023, Ionis Pharmaceuticals Inc's Revenue amounts to 787.6m USD.
What is Ionis Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
18%
Over the last year, the Revenue growth was 34%. The average annual Revenue growth rates for Ionis Pharmaceuticals Inc have been 3% over the past three years , 6% over the past five years , and 18% over the past ten years .